| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/10/2002 | US6448284 Substituted tricyclics |
| 09/10/2002 | US6448274 Fluoroalkoxy-substituted benzamide dichloropyridinyl N-oxide PDE4 inhibitor |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 09/10/2002 | US6448245 Methods of and compounds for inhibiting calpains |
| 09/10/2002 | US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation |
| 09/10/2002 | US6448054 Locally administering to a specific site a fugetactic agent in an amount effective to repel immune cells |
| 09/10/2002 | CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors |
| 09/10/2002 | CA2129339C Inhibitors of thrombosis |
| 09/06/2002 | WO2002068642A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 09/06/2002 | WO2002068469A2 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | WO2002068458A2 Disintegrin homolog, zsnk16 |
| 09/06/2002 | WO2002068440A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/06/2002 | WO2002068439A1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 09/06/2002 | WO2002068425A1 Aminomethyl-pyrroloquinazoline compounds as thrombin receptor antagonists |
| 09/06/2002 | WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors |
| 09/06/2002 | WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 09/06/2002 | WO2002068390A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | WO2002067981A1 Blood coagulation factor xiii for treating platelet disorders |
| 09/06/2002 | WO2002067980A1 Method for treating von willebrand's disease |
| 09/06/2002 | WO2002067957A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | WO2002067956A2 Method for purifying a biological composition |
| 09/06/2002 | WO2002067950A1 Vascular regeneration promoters |
| 09/06/2002 | WO2002067935A1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067907A1 Compositions and methods for preventing platelet aggregation |
| 09/06/2002 | WO2002067869A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/06/2002 | WO2002067857A2 Modified annexin proteins and methods for preventing thrombosis |
| 09/06/2002 | WO2002067851A2 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | WO2002067760A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 09/06/2002 | WO2002057225A3 Thrombin inhibitors |
| 09/06/2002 | WO2002043648A8 Compounds active at the glucocorticoid receptor ii |
| 09/06/2002 | WO2002040517A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002040037A3 M. tuberculosis chaperonin 60.1 and uses thereof |
| 09/06/2002 | WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors |
| 09/06/2002 | WO2002005796A3 Use of a spla2 inhibitor for the treatment of sepsis |
| 09/06/2002 | WO2001092565A3 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription |
| 09/06/2002 | WO2001005944A9 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/06/2002 | CA2756609A1 Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| 09/06/2002 | CA2439168A1 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | CA2439119A1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 09/06/2002 | CA2438761A1 Method for treating von willebrand's disease |
| 09/06/2002 | CA2437114A1 Diamides which inhibit tryptase and factor xa activity |
| 09/06/2002 | CA2435848A1 Method for purifying a biological composition |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2433425A1 Method for treating fibrotic diseases or other indications iiic |
| 09/06/2002 | CA2410802A1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 09/05/2002 | US20020123520 3',5'-cyclic nucleotide phosphodiesterases (PDEs); disease related to eosinophils, such as asthma, chronic bronchitis, and chronic obstructuive pulmonary disease |
| 09/05/2002 | US20020123510 Administering an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
| 09/05/2002 | US20020123484 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123030 Deactivating a viral sample; obtain sample containing virus, incubate with quenching agent, separate viral particles from sample fluid |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/05/2002 | DE10109861A1 Neuartige seitenkettenhalogenierte Aminodicarbonsäurederivate Novel side-chain halogenated Aminodicarbonsäurederivate |
| 09/05/2002 | DE10109859A1 Neuartige Aminodicarbonsäurederivate Novel Aminodicarbonsäurederivate |
| 09/04/2002 | EP1236735A1 Benzamidine derivatives |
| 09/04/2002 | EP1236712A1 Amidinophenylpyruvic acid derivative |
| 09/04/2002 | EP1236711A2 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood |
| 09/04/2002 | EP1236468A1 Sulfonylaminocarbonyl derivatives for the treatment of nuclear factor-kappa B mediated diseases and disorders |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235814A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS |
| 09/04/2002 | EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa |
| 09/04/2002 | EP1235593A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 09/04/2002 | EP1235592A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-$g(a) AND CD95L IN A MEDICAMENT |
| 09/04/2002 | EP1235586A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 09/04/2002 | EP1235569A2 Medicament and combination of compatible medicaments |
| 09/04/2002 | EP1235567A2 Inhibitors of collagen-induced platelet aggregation |
| 09/04/2002 | EP1150974B1 Heterocyclic derivatives as inhibitors of factor xa |
| 09/04/2002 | EP0969828B1 Butyrate prodrugs derived from lactic acid |
| 09/04/2002 | EP0809636B1 Substituted isoxazoles for the treatment of inflammation |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0746551B1 Optically pure 4-aryl-2-hydroxytetronic acids |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors |
| 09/04/2002 | CN1367816A Fat compositions |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367777A Benzenamine derivatives as anti-coagulants |
| 09/04/2002 | CN1367701A Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2002 | CN1367696A Method of enhancing insulin action |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367176A Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |
| 09/04/2002 | CN1367019A Thrombase capable of carrying about and its preparation method |
| 09/04/2002 | CN1367001A Capsule for reducing blood-lipid and preventing thrombosis |
| 09/04/2002 | CN1366971A Nano lotus leaf preparation medicine and preparation method |
| 09/04/2002 | CN1366961A Nano Duanxueliu preparation medicine and preparation method |
| 09/04/2002 | CN1366958A Nano Dieda Huoxue preparation medicine for curing traumatic injuries and preparation method |
| 09/04/2002 | CN1366955A Nano ass hide glue preparation medicine and preparation method |
| 09/04/2002 | CN1366948A Nano Fufang Fufangteng preparation medicine and preparation method |
| 09/04/2002 | CN1366946A Nano Ganshenkang preparation medicine and preparation method |
| 09/04/2002 | CN1366934A Nano Huichunruyi preparation medicine amd preparation method |
| 09/04/2002 | CN1366933A Nano Qiyeshen'an preparation medicine and preparation method |
| 09/04/2002 | CN1090029C Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |